We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Health Canada May Allow Sponsors to Skirt Human Bioavailability Studies
Health Canada May Allow Sponsors to Skirt Human Bioavailability Studies
September 26, 2012
Drug sponsors may be able to avoid establishing in vivo bioequivalence as part of safety and efficacy data requirements in situations where in vitro data provides a reasonable estimate of the relative in vivo performance of the two products, according to a new Health Canada draft guidance.